Adenocarcinoma Of Esophagus Recruiting Phase 4 Trials for Oxaliplatin (DB00526)

Back to Adenocarcinoma Of Esophagus

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

Indication	Status	Phase
DBCOND0067383 (Adenocarcinoma Of Esophagus)	Recruiting	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02366819	Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)